These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4268482)

  • 41. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen.
    McClintock DK; Englert ME; Dziobkowski C; Snedeker EH; Bell PH
    Biochemistry; 1974 Dec; 13(26):5334-44. PubMed ID: 4279693
    [No Abstract]   [Full Text] [Related]  

  • 42. Isolation and characterization of N-terminal fragments obtained by plasmin digestion of human fibrinogen.
    Iwanaga S; Wallén P; Gröndahl NJ; Henschan A; Blombäck B
    Biochim Biophys Acta; 1967 Dec; 147(3):606-9. PubMed ID: 4230076
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of plasmin on the subunit structure of human fibrinogen.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Biol Chem; 1972 Feb; 247(3):636-45. PubMed ID: 4258027
    [No Abstract]   [Full Text] [Related]  

  • 45. A sensitive fluorimetric assay of plasmin and plasminogen.
    Seelich T; Astrup T; Furlan M; Beck EA
    Biochem Med; 1977 Apr; 17(2):202-14. PubMed ID: 16588
    [No Abstract]   [Full Text] [Related]  

  • 46. High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule.
    Budzyński AZ; Stahl M; Kopeć M; Latallo ZS; Wegrzynowicz Z; Kowalski E
    Biochim Biophys Acta; 1967 Oct; 147(2):313-23. PubMed ID: 4229214
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasmic degradation of human fibrinogen. II. Further characterization of fragment D.
    Furlan M; Beck EA
    Biochim Biophys Acta; 1973 May; 310(1):205-16. PubMed ID: 4197006
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasminogen activator formed by reaction of streptokinase with human plasminogen.
    Ts'ao CH; Kline DL
    J Appl Physiol; 1969 May; 26(5):634-9. PubMed ID: 4238461
    [No Abstract]   [Full Text] [Related]  

  • 49. Structural studies on normal horse immunoglobulin light chains. Detection of k-type N-terminal sequences.
    Gibson D
    Biochemistry; 1974 Jun; 13(13):2776-85. PubMed ID: 4847545
    [No Abstract]   [Full Text] [Related]  

  • 50. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzymatic assay for the combined determination of plasmin plus plasminogen in milk: revisited.
    Politis I; Zavizion B; Barbano DM; Gorewit RC
    J Dairy Sci; 1993 May; 76(5):1260-7. PubMed ID: 8505418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1970 Oct; 221(1):20-30. PubMed ID: 4248689
    [No Abstract]   [Full Text] [Related]  

  • 53. [Plasminogen (PG), plasmin (PM)].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():667-70. PubMed ID: 10543208
    [No Abstract]   [Full Text] [Related]  

  • 54. [Plasminogen (PG), plasmin (PM)].
    Sakuragawa N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():51-4. PubMed ID: 8753178
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Plasminogen and plasmin determination in human plasma].
    Bruhn HD; Müller L; Duckert F
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1650. PubMed ID: 4235242
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasminogen-plasmin system. I. Purification and properties of human plasminogen.
    Abiko Y; Iwamoto M; Shimizu M
    J Biochem; 1968 Dec; 64(6):743-50. PubMed ID: 4238315
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasminogen-plasmin system. II. Purification and properties of human plasmin.
    Abiko Y; Iwamoto M; Shimizu M
    J Biochem; 1968 Dec; 64(6):751-7. PubMed ID: 4238016
    [No Abstract]   [Full Text] [Related]  

  • 59. Human serum plasminogen antiactivator: its distinction from antiplasmin.
    Aoki N; Von Kaulla KN
    Am J Physiol; 1971 Apr; 220(4):1137-45. PubMed ID: 4251631
    [No Abstract]   [Full Text] [Related]  

  • 60. Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.
    Nilsson UR; Tomar RH; Taylor FB
    Immunochemistry; 1972 Jul; 9(7):709-23. PubMed ID: 4261220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.